Central Serous Retinopathy (CSR) is a retinal condition that can cause blurred or distorted central vision. It often affects young and middle-aged adults. Stress, steroid use, and certain personality traits have been associated with an increased risk of CSR. Even when the eye appears normal externally, Central Serous Retinopathy can cause fluid to accumulate beneath the retina and affect vision. Early diagnosis with retinal examination and OCT imaging helps guide appropriate management and follow-up, says Dr Shibal Bhartiya. It is also called CSCR, or central serous chorioretinopathy
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
Sudden Vision Loss in Pregnancy
Ms MK was 34 weeks pregnant when the vision in her left eye began to fade. It happened over three days, not suddenly, but steadily enough that she noticed it getting worse each morning. There was no pain. No redness. Nothing on the surface of her eye looked different when she checked in the mirror.
She had assumed pregnancy itself was simply affecting her eyes. The way it can affect so much else in the body. By the third day, reading her phone with her left eye alone had become difficult. That is when she came to see me.
Her vision in the right eye was normal. In the left eye, it had dropped significantly. Her vision did not improve even with a pinhole test, which usually rules out a simple focusing problem. The near vision in that eye was also reduced.
I looked at the back of the left eye. There it was: a large area of fluid had collected beneath the retina. It stretched from her macula all the way to the optic nerve. An OCT scan confirmed it clearly, a wide pocket of fluid lifting the retina away from the tissue beneath it.
I checked with her, and her obstetrician for any diabetes, hypertension, protein in the urine, or any signs of pre-eclampsia. All were negative.
This was central serous retinopathy, a condition where fluid leaks beneath the retina and causes exactly the kind of painless, progressive vision loss MK had described. In her case, it was directly related to her pregnancy.
Patient details have been changed to protect privacy.
What is CSR?
This case highlights something many pregnant women are never told. CSR, central serous retinopathy, also called CSCR, central serous chorioretinopathy, may present in the third trimester. This is driven by the same hormonal changes that support pregnancy itself. It is rarely dangerous to the baby. The only real question is about safe treatment, since many standard medications are unsuitable in pregnancy.
Below, I explain why CSCR occurs in pregnancy. I also discuss how it is managed safely, and what monitoring is needed for both mother and baby.
Quick Answer: Central serous retinopathy, a build-up of fluid beneath the retina, can happen in the third trimester of pregnancy. This due to elevated cortisol and other hormonal changes. It usually does not affect the baby and often improves after delivery. It requires careful monitoring and pregnancy-safe management throughout.
Central serous retinopathy occurs when fluid leaks through the retinal pigment epithelium, a layer of cells beneath the retina that normally acts as a barrier. This fluid collects and lifts the retina away from its supporting tissue, distorting and dimming vision in the affected area. CSCR has several recognised triggers, and elevated cortisol sits at the centre of most of them. It is classically seen in people under chronic stress, in those using steroid medications of any kind, including nasal sprays and skin creams. It is more common in people with a particular personality profile often described as Type A. Men in their thirties and forties are traditionally the most affected group outside pregnancy. Other associations include sleep disruption, certain autoimmune conditions, and, less commonly, no identifiable trigger at all.
Why Pregnancy Increases the Risk of Central Serous Retinopathy
Central serous retinopathy occurs when fluid leaks through the retinal pigment epithelium, a layer of cells beneath the retina that normally acts as a barrier. This fluid collects and lifts the retina away from its supporting tissue, distorting and dimming vision in the affected area.
Elevated cortisol is the strongest known driver of CSCR. This is why CSCR, while uncommon overall, appears disproportionately in pregnant women. This is usually seen the final trimester. It almost always resolves on its own after delivery as hormone levels return to baseline.
The challenge in pregnancy is not the diagnosis itself, which is usually straightforward on OCT imaging. The challenge is management. Many of the medications and procedures used for CSCR outside pregnancy, including certain oral anti-inflammatory drugs, are not appropriate for a pregnant patient, particularly in the third trimester. This is where management has to be adapted carefully, balancing the mother’s vision against the safety of the pregnancy.
In MK’s case, I avoided oral non-steroidal anti-inflammatory medication entirely, given the risks these carry in late pregnancy. Instead, I used topical nepafenac, applied with punctal occlusion. This technique involves gentle pressure on the inner corner of the eye after applying drops. It reduces how much medication drains into the tearduct and enters the bloodstream. This keeps treatment almost entirely local to the eye, which makes it a safe option even in the third trimester.
I also arranged blood pressure measurement, urine protein testing, and a blood sugar check. Pre-eclampsia and gestational diabetes can occasionally present with or worsen retinal fluid changes. MK’s results were normal on all counts.
CSCR in Pregnancy: What Helps Track and Manage It
| Symptom or Step | What It Suggests | What To Do |
|---|---|---|
| Painless, progressive blur in one eye in the third trimester | Possible CSCR related to pregnancy hormones | Dilated retinal exam and OCT scan promptly |
| Vision not improving with a pinhole test | Suggests a retinal cause rather than a simple refractive change | OCT imaging to look for subretinal fluid |
| Distorted central vision or difficulty reading | Fluid affecting the macula directly | Amsler grid self-monitoring alongside specialist review |
| Concern about medication safety in pregnancy | Many oral anti-inflammatory drugs are unsafe in the third trimester | Topical treatment with punctal occlusion, used under specialist guidance |
| Vision change alongside headache, swelling, or high blood pressure | Possible pre-eclampsia affecting the retina, not isolated CSCR | Urgent obstetric review alongside eye assessment |
| Vision not fully resolved by the time of delivery | CSCR can take weeks to months to settle after hormone levels normalise | Continued monitoring with OCT in the postpartum period |
Why This Diagnosis Is So Often Missed
The first reason is that pregnant women are rarely told that pregnancy itself can affect the retina. Vision changes are commonly attributed to fluid retention, blood pressure changes, or simple fatigue, and many genuinely are. This means a retinal cause like CSCR is often the last thing considered. Even though it has a clear and well-documented hormonal link to late pregnancy.
The second reason is that CSCR causes no pain and no visible change to the eye. Meera checked her eye in the mirror and saw nothing unusual, which is exactly what would be expected. The pathology is entirely internal, visible only on dilated examination and OCT.
The third reason is treatment hesitancy. Many clinicians are appropriately cautious about treating any condition in pregnancy. Many may choose to simply observe. This is often reasonable for CSCR. But this caution can sometimes prevent women from being told what their safe options actually are, including topical treatments that carry negligible systemic risk when used correctly.
When To See a Specialist During Pregnancy
Seek a dilated eye examination promptly if you are pregnant and notice any of the following:
- Blurred or dimmed vision in one eye, even without pain
- Vision that does not improve when you try to refocus or squint
- Straight lines appearing distorted or wavy
- Vision changes alongside headache, swelling, or known high blood pressure
- Any visual change in the second or third trimester that persists beyond a day or two
A retinal examination and OCT scan are both safe and painless during pregnancy.
Read about eye care in pregnancy.
Frequently Asked Questions
Can central serous retinopathy harm my baby?
CSCR itself does not directly affect the baby. However, vision changes in pregnancy should always be checked, since blood pressure or sugar-related conditions can occasionally present similarly.
Will my vision return to normal after delivery?
In most cases, yes. CSCR related to pregnancy commonly improves over weeks to months after delivery as hormone levels return to baseline, though continued monitoring is important.
Are eye drops safe to use during pregnancy?
Many topical eye drops, including nepafenac, are safe in pregnancy when applied with punctal occlusion to limit systemic absorption. Oral medications require much more caution, particularly in the third trimester.
Why did the pinhole test not improve my vision?
A pinhole test improves vision when the problem is a simple focusing error. It does not improve vision caused by fluid or damage within the retina itself. This points toward a retinal cause requiring imaging.
Book a Consultation
If you are pregnant and experiencing any change in vision, particularly in the third trimester, a prompt eye examination is the safest next step. Many causes are manageable, and treatment options exist that are safe for both you and your baby.
With Dr Shibal Bhartiya in Gurugram, assessment includes a comprehensive eye examination, and OCT imaging, if required. And a pregnancy-safe treatment planning in coordination with your obstetrician.
[Book an Appointment → www.drshibalbhartiya.com | +91 88826 38735]
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks. These span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1500+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID
Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735
Leave a review on Google